miR ‐335‐5p inhibits endochondral ossification by directly targeting SP1 in TMJ OA
Oral Diseases · 2024
DOI: 10.1111/odi.14736 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral Diseases, 2024. Verfasst von Simo Xia und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Surgery, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai, Chi…. Hauptthemen laut MEDLINE: MicroRNAs, Osteoarthritis, Osteogenesis, Sp1 Transcription Factor. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: General Program of National Natural Science Foundation of China.
Abstract (Originalsprache)
Objective
During the development of temporomandibular joint osteoarthritis, endochondral ossification is compromised which leads to condylar degeneration; miR‐335‐5p in endochondral ossification in osteoarthritic condylar cartilage tissue remains unclear.
Methods
Up‐regulated microRNA and its target gene were searched for endochondral ossification in osteoarthritis articular cartilage. The effect of increased or decreased miR‐335‐5p on endochondral ossification was evaluated by transfecting miR‐335‐5p mimics or miR‐335‐5p inhibitor in vitro in chondrocytes C28/I2. Finally, we injected the temporomandibular joint of rats intra‐articularly with agomiR‐335 in a unilateral anterior crossbite rat model to determine the in vivo regulation of miR‐335.
Results
After the onset of temporomandibular joint osteoarthritis, miR‐335‐5p levels were gradually up‐regulated, whereas endochondral ossification‐related genes were down‐regulated in condylar cartilage specimens. Our results showed that miR‐335 inhibited endochondral ossification after administration of a miR‐335 antagonist into the temporomandibular joint articular cavity of a unilateral anterior crossbite rat model. AgomiR‐335, a miR‐335 agonist, inhibited matrix mineralization in fibrocartilage stem cells in vitro and then miR‐335‐5p negatively regulated chondrocyte activity by directly targeting SP1 via promoting transforming growth factor‐β/Smad signalling. Conclusion miR‐335‐5p can significantly inhibit endochondral ossification; therefore, its inhibition may be beneficial for the treatment of temporomandibular joint osteoarthritis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral Surgery, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Förderung
- General Program of National Natural Science Foundation of China
Zitieren
APA
Xia, S., Zhao, J., Zhang, D., Chen, L., Zhang, Y., Shen, P., & Yang, C. (2024). miR ‐335‐5p inhibits endochondral ossification by directly targeting SP1 in TMJ OA. Oral Diseases. https://doi.org/10.1111/odi.14736
Vancouver
Xia S, Zhao J, Zhang D, Chen L, Zhang Y, Shen P, et al. miR ‐335‐5p inhibits endochondral ossification by directly targeting SP1 in TMJ OA. Oral Diseases. 2024. doi:10.1111/odi.14736
BibTeX
@article{Xia2024,
author = {Xia, Simo and Zhao, Jiong and Zhang, Dahe and Chen, Lu and Zhang, Yuxin and Shen, Pei and Yang, Chi},
title = {miR ‐335‐5p inhibits endochondral ossification by directly targeting SP1 in TMJ OA},
journal = {Oral Diseases},
year = {2024},
doi = {10.1111/odi.14736}
}
EUVIMED